Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone

European Urology

Volumn 52, Issue 1, 2007, Pages 163-169

  Toyoda, Yutaka ^a   Shinohara, Nobuo ^a   Harabayashi, Toru ^a   Abe, Takashige ^a   Akino, Tomoshige ^a   Sazawa, Ataru ^a   Nonomura, Katsuya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metastasis; Local management; Prognosis; Renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

ADULT; AGED; BONE NEOPLASMS; CARCINOMA, RENAL CELL; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34249102574     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.10.060     Document Type: Article

References (22)

1. Motzer R.J., Bander N.H., and Namus D.M. Renal cell carcinoma. N Engl J Med 335 (1996) 865-875
2. Mani S., Todd M.B., Katz K., and Poo W.L. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol 154 (1995) 35-40
3. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using integrated staging system. J Clin Oncol 19 (2001) 1649-1657
4. Zekri J., Ahmed N., Coleman R.E., and Hancock B.W. The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 19 (2001) 379-382
5. Han K.R., Pantuck A.J., Bui M.H.T., et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology 61 (2003) 314-319
6. Martel C.L., and Lara P.N. Renal cell carcinoma: current status and future directions. Crit Rev Oncol Haematol 45 (2003) 177-190
7. Flanigan R.C., Campbell S.C., Clark J.I., and Picken M.M. Metastatic renal cell carcinoma. Curr Treat Options Oncol 4 (2003) 385-390
8. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
9. Mantel N. Evaluation of survival date and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
10. Cox D.R., and Oakes D. Analysis of survival data (1990), Chapman and Hall, New York
11. Citterio G., Bertuzzi A., Tresoldi M., et al. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients. Eur Urol 31 (1997) 286-291
12. Motzer R.J., Mazumder M., Bacik J., Russo P., Berg W.J., and Metz E.M. Effect of cytokine therapy of survival of patients with advanced renal cell carcinoma. J Clin Oncol 18 (2000) 1928-1935
13. Fisher R.I., Rosenberg S.A., and Fyte G. Long term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. Cancer J Sci Am 6 (2000) 555-557
14. Negrier S., Escudier B., Gomez F., et al. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol 13 (2002) 1460-1468
15. Maldazys J.D., and deKernion J.B. Prognostic factors in metastatic renal carcinoma. J Urol 136 (1986) 376-379
16. Thompson I.M., Shannon H., Ross J., and Montie J. An analysis of factors affecting survival in 150 patients with renal cell carcinoma. J Urol 114 (1975) 694-696
17. Jung S.T., Ghert M.A., Harrelson J.M., and Scully S.P. Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res 409 (2003) 223-231
18. Althausen P., Althausen A., Jennings L.C., and Mankin H.J. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer 80 (1997) 1103-1109
19. Tobisu K., Kakizoe T., Takai K., and Tanaka Y. Prognosis in renal cell carcinoma: analysis of clinical course following nephrectomy. Jpn J Clin Oncol 19 (1989) 142-148
20. Leibovich B.C., Cheville J.C., Lohse C.M., et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 174 (2005) 1759-1763
21. Saad F., and Lipton A. Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers. BJU Int 96 (2005) 964-969
22. Lipton A., Zheng M., and Seaman J. Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma. Cancer 98 (2003) 962-969